BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clin Rheumatol. 2018;37:1295-1303. [PMID: 28748509 DOI: 10.1007/s10067-017-3776-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Sarecka-Hujar B, Kopyta I. Antiphospholipid syndrome and its role in pediatric cerebrovascular diseases: A literature review. World J Clin Cases 2020; 8(10): 1806-1817 [PMID: 32518771 DOI: 10.12998/wjcc.v8.i10.1806] [Reference Citation Analysis]
2 Soybilgic A, Avcin T. Pediatric APS: State of the Art. Curr Rheumatol Rep 2020;22:9. [PMID: 32124078 DOI: 10.1007/s11926-020-0887-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Guo Q, Lou Y, Liu L, Luo P. How Can I Manage Thrombocytopenia in Hemodialysis Patient? A Review. Ther Apher Dial 2020;24:352-60. [DOI: 10.1111/1744-9987.13448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Chayoua W, Kelchtermans H, Moore GW, Musiał J, Wahl D, de Laat B, Devreese KMJ. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays. J Thromb Haemost 2018;16:2016-23. [PMID: 30079628 DOI: 10.1111/jth.14261] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
5 Chiang YJ, Hu YC, Chiang BL. A significant improvement of thromboses treated by a new oral anticoagulant in an 11-year-old girl with systemic lupus erythematosus associated antiphospholipid syndrome: A case report. Lupus 2021;30:1338-41. [PMID: 34000880 DOI: 10.1177/09612033211016096] [Reference Citation Analysis]
6 Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-García A. Epidemiology of Antiphospholipid Syndrome in the General Population. Curr Rheumatol Rep 2022;23:85. [PMID: 34985614 DOI: 10.1007/s11926-021-01038-2] [Reference Citation Analysis]
7 Rosina S, Chighizola CB, Ravelli A, Cimaz R. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management. Curr Rheumatol Rep 2021;23:10. [PMID: 33511497 DOI: 10.1007/s11926-020-00976-7] [Reference Citation Analysis]
8 Torres-jimenez A, Ramirez-nova V, Cespedes-cruz AI, Sanchez-jara B, Velazquez-cruz A, Bekker-méndez VC, Guerra-castillo FX. Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence. Pediatr Rheumatol 2022;20. [DOI: 10.1186/s12969-022-00673-y] [Reference Citation Analysis]
9 Prothro I, Reuter-Rice K. Symptoms of Mild Traumatic Brain Injury Unmask Autoimmune Disease. J Pediatr Health Care 2020;34:161-5. [PMID: 31836353 DOI: 10.1016/j.pedhc.2019.11.004] [Reference Citation Analysis]
10 Yan HB, Li YM. Atrial thrombus as a complication of SLE and APS in an 8-year-old child. Pediatr Rheumatol Online J 2020;18:90. [PMID: 33203428 DOI: 10.1186/s12969-020-00484-z] [Reference Citation Analysis]
11 Wincup C, Ioannou Y. The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome. Front Pediatr 2018;6:362. [PMID: 30542645 DOI: 10.3389/fped.2018.00362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 Madison JA, Gockman K, Hoy C, Tambralli A, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series. Pediatr Rheumatol Online J 2022;20:17. [PMID: 35197077 DOI: 10.1186/s12969-022-00677-8] [Reference Citation Analysis]
13 Islabão AG, Mota LMH, Ribeiro MCM, Arabi TM, Cividatti GN, Queiroz LB, Andrade DC, Sakamoto AP, Trindade VC, Novak GV, Molinari BC, Campos LM, Aikawa NE, Pereira RMR, Terreri MT, Magalhães CS, Marini R, Gomes HR, Silva MF, Oliveira SK, Sztajnbok FR, Sacchetti SB, Bica BE, Sena EG, Moraes AP, Santos MC, Robazzi TC, Spelling PF, Scheibel IM, Cavalcanti AS, Naka EN, Guimarães LJ, Santos FP, Sampaio MC, Bonfá E, Silva CA; Brazilian Childhood-onset Systemic Lupus Erythematosus Group. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients. Autoimmun Rev 2020;19:102693. [PMID: 33164791 DOI: 10.1016/j.autrev.2020.102693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chaudhary H, Jindal P, Pandiarajan V, Kumar J, Sudhakar M, Ezhumalai G, Nada R, Gupta K. Portal vein thrombosis, livedo reticularis, polymicrobial sepsis and high antiphospholipid antibody titers in a newborn: A clinicopathological conference of antiphospholipid-associated neonatal syndrome. Lupus 2021;30:141-8. [PMID: 33086918 DOI: 10.1177/0961203320967418] [Reference Citation Analysis]
15 Tarango C, Palumbo JS. Antiphospholipid syndrome in pediatric patients. Curr Opin Hematol 2019;26:366-71. [PMID: 31348049 DOI: 10.1097/MOH.0000000000000523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Miyamae T, Kawabe T. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome. J Clin Med 2021;10:1240. [PMID: 33802787 DOI: 10.3390/jcm10061240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Baleeiro C, Duran CS, Signorelli F, Balbi GG, Bonfá E, Andrade DC. Distinct features of youth-onset primary antiphospholipid syndrome. Lupus 2021;30:1888-95. [PMID: 34634966 DOI: 10.1177/09612033211038054] [Reference Citation Analysis]
18 Madison JA, Duarte-García A, Zuo Y, Knight JS. Treatment of thrombotic antiphospholipid syndrome in adults and children. Curr Opin Rheumatol 2020;32:215-27. [PMID: 32187042 DOI: 10.1097/BOR.0000000000000702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Islabão AG, Trindade VC, da Mota LMH, Andrade DCO, Silva CA. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects. Paediatr Drugs 2021. [PMID: 34904182 DOI: 10.1007/s40272-021-00484-w] [Reference Citation Analysis]
20 Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2019;1-10. [PMID: 31804173 DOI: 10.5152/eurjrheum.2019.19160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]